Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study
暂无分享,去创建一个
J. Carles | E. Gallardo | A. González del Alba | B. Mellado | A. Font | M. Doménech | J. González-Larriba | G. Catalán | Julio C. Tello | P. Lianes | M. Nogué | J. Alfaro